next step, page-4

Hi James

EMS will not take the product to the market in my view - the product is just to important and needed for them to be able to handle it - they will invite and ultimately get a trade sale (sell the project for cash and hopefully get a royalty) - with the other parts of the business gone the whole operation becomes more highly focused on the Bio side of things which is a plus - after speaking with Mike (the white knight) it seems that this is the most preferred option to them

Commercialisation is really only an option of last resort - stop for a second and consider how much money would be required to bring this to market

Mike also praised Dermy for his efforts so it would seem that the management of the company has turned the corner and a lot of the behind the scenes stuff has been completed

Just in case Mike or Dermy read this post (and I know Dermy does from time to time) - I would suggest the following for them to consider - the biggest problem with EMS is that as a Bio company they can not afford to say something that is not true and can’t be substantiated with facts - unfortunately this Bio standard of thinking has lead us into the situation where the broader market does not understand the project and it's implications for the company - instead EMS have let Pato's do the spruiking for them - trouble is people need reminding from time to time and neither company is doing that - hidden benefit is we get to pick up more shares cheaply

Clyde

Just my ramblings